Cargando…
Development of prognostic signature and nomogram for patients with breast cancer
To identify prognostic signature that could predict the survival of patients with breast cancer (BC). Breast cancer samples and normal breast tissues in the TCGA-BRCA and GSE7390 were included. Differentially expressed genes (DEGs) were identified using the “limma” method. Overall survival (OS) asso...
Autores principales: | Su, Jiao, Miao, Li-Feng, Ye, Xiang-Hua, Cui, Meng-Shen, He, Xiao-Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6426514/ https://www.ncbi.nlm.nih.gov/pubmed/30882627 http://dx.doi.org/10.1097/MD.0000000000014617 |
Ejemplares similares
-
Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer
por: Wen, Jiahuai, et al.
Publicado: (2016) -
Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer
por: Yan, Xin, et al.
Publicado: (2021) -
Combined effects of GSTM1 and GSTT1 polymorphisms on breast cancer risk: A MOOSE-compliant meta-analysis and false-positive report probabilities test
por: Miao, Li-Feng, et al.
Publicado: (2019) -
Development of Autophagy Signature-Based Prognostic Nomogram for Refined Glioma Survival Prognostication
por: Fan, Yuxiang, et al.
Publicado: (2020) -
Construction and validation of prognostic nomogram for metaplastic breast cancer
por: Li, Yongfeng, et al.
Publicado: (2022)